Design and evaluation of a two-layer floating tablet for gastric retentionusing cisapride as a model drug

Citation
Zp. Wei et al., Design and evaluation of a two-layer floating tablet for gastric retentionusing cisapride as a model drug, DRUG DEV IN, 27(5), 2001, pp. 469-474
Citations number
9
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
ISSN journal
03639045 → ACNP
Volume
27
Issue
5
Year of publication
2001
Pages
469 - 474
Database
ISI
SICI code
0363-9045(2001)27:5<469:DAEOAT>2.0.ZU;2-D
Abstract
A new kind of two-layer floating tablet for gastric retention (TFTGR) with cisapride as a model drug was developed. The in vitro drug release was dete rmined, and the resultant buoyancy and the time-buoyancy curve were plotted . Because of the sodium bicarbonate added to the floating layer when immers ed in simulated gastric fluid (SGF) the tablet expands and rises to the sur face, where the drug is gradually released. The in vitro drug release of th is kind of two-layer dosage was controlled by the amount of hydroxypropylme thylcellulose (HPMC) in the drug-loading layer. Generally, the more HPMC, t he slower the drug releases. Because cisapride has greater solubility in SG F than simulated intestinal fluid (SIF), its in vitro drug dissolution in S GF is faster than in SIF, One of the distinguishing characteristics of this kind of tablet is the separate regulation of buoyancy and drug release. Th e idea developed in this experiment can be used as a general model for the design of other tablets for gastric retention.